APYX — APYX MEDICAL CORPORATION

Ownership history in XTX Topco Ltd · 5 quarters on record

This page tracks every 13F SEC filing in which XTX Topco Ltd reported a position in APYX MEDICAL CORPORATION (APYX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position

0.01% (2023 Q4)

Avg. % of fund

0.01%

First filed

2022 Q4

Last filed

2025 Q3

Quarters held

5

Quarter	Action	Shares	Change	Chg %	% of Fund	Mkt Value	Price (EOQ)
2025 Q3	ADDED	21,545	+7,432	+52.7%	0.00%	$46K	$2.14
2024 Q1	REDUCED	14,113	-6,890	-32.8%	0.00%	$19K	$1.36
2023 Q4	ADDED	21,003	+9,534	+83.1%	0.01%	$55K	$2.62
2023 Q2	REDUCED	11,469	-8,902	-43.7%	0.01%	$58K	$5.03

% of Fund (quarterly) APYX price (monthly, adj. close)

Other funds also holding APYX

As of 2025 Q4 — sorted by position size

Archon Capital Management LLC 3Y 7Y 6.4% Silverberg Bernstein Capital Management LLC 2.09% AIGH Capital Management LLC 3Y 0.94% Taylor Frigon Capital Management LLC 3Y 7Y 0.78% Nantahala Capital Management, LLC 3Y 7Y 0.46% PERKINS CAPITAL MANAGEMENT INC 3Y 7Y 0.24% Informed Momentum Co LLC 3Y 7Y 0.1% ROYCE & ASSOCIATES LP 3Y 7Y 0.09% RPg Family Wealth Advisory, LLC 3Y 7Y 0.06% SCHOLTZ & COMPANY, LLC 3Y 7Y 0.03%

← Back to XTX Topco Ltd Holdings